On-Sight Interview With Antony Mattessich, President & CEO, Ocular Therapeutix at OIS@AAO 2019

Antony Mattessich of Ocular Therapeutix discusses the company’s first launch (Dextenza), the ins and outs of drug delivery technology and formulations, and what the future holds for sustained release products.

This video is from OIS@AAO 2019 – Register for our next Ophthalmology Innovation Summit today.